Infinity Pharmaceuticals Management Performance Evaluation

INFI -- USA Stock  

USD 1.91  0.07  3.54%

Analysis of Infinity Pharmaceuticals manpower and management performance can provide insight into Infinity Pharmaceuticals stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Infinity Pharmaceuticals future performance. Please also check Risk vs Return Analysis.

Infinity Pharmaceuticals Management Effectiveness

The company has return on total asset (ROA) of (28.88) % which means that it has lost $28.88 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (68.47) % meaning that it created substantial loss on money invested by shareholders.

Infinity Pharmaceuticals Workforce Comparison

Infinity Pharmaceuticals is rated below average in number of employees category among related companies. The total workforce of Pharmaceutical Products industry is currently estimated at about 1,728. Infinity Pharmaceuticals claims roughly 22.0 in number of employees contributing just under 2% to equities listed under Pharmaceutical Products industry.

Infinity Pharmaceuticals Insider Trading

Infinity Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of seventeen. Infinity Pharmaceuticals Price Series Summation is a cross summation of Infinity Pharmaceuticals price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Infinity Pharmaceuticals Stakeholders

Adelene Perkins Chairman of The Board, CEO and Pres
Joseph Pearlberg Vice President - Clinical Development
Melissa Hackel Vice President - Finance
William Bertrand Executive Vice President General Counsel
Lawrence Bloch CFO, Executive Vice President Chief Business Officer
Julian Adams President of RandD
Sujay Kango Executive Vice President Chief Commercial Officer
Vito Palombella Chief Scientific Officer and Executive VP
Jeffrey Berkowitz Independent Director
Norman Selby Lead Outside Independent Director
Jose Baselga Independent Director
Michael Venuti Independent Director
Michael Kauffman Independent Director
Eric Lander Independent Director
David Beier Independent Director
Anthony Evnin Independent Director
Gwendolyn Fyfe Independent Director
Ian Smith Independent Director

Leadership

Infinity Pharmaceuticals Top Executives
  Adelene Perkins  Chairman
Chairman of The Board, CEO and Pres
  Joseph Pearlberg  President
Vice President - Clinical Development

Infinity Pharmaceuticals Employment Tenure

Infinity Pharmaceuticals employes about 22 people. The company is managed by 18 executives with total tenure of roughly 80 years, averanging almost 4.0 years of service per executive having 1.0 employee per reported executive.

Return on Infinity Pharmaceuticals Manpower

Revenue Per Employee 578 K
Revenue Per Executive 333.3 K
Net Loss Per Employee 680.3 K
Net Loss Per Executive 2.3 M
Working Capital Per Employee 8.4 M
Working Capital Per Executive 10.3 M

Per Employee

Infinity Pharmaceuticals Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Please also check Risk vs Return Analysis. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">